title: Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
authors.forename: A J
authors.initials: AJ
authors.lastname: Mueller
authors.forename: M A
authors.initials: MA
authors.lastname: Jacobson
authors.forename: S
authors.initials: S
authors.lastname: Hurwitz
authors.forename: E L
authors.initials: EL
authors.lastname: Chuang
authors.forename: D N
authors.initials: DN
authors.lastname: Friedberg
authors.forename: S J
authors.initials: SJ
authors.lastname: Haidt
authors.forename: M H
authors.initials: MH
authors.lastname: Heinemann
authors.forename: D A
authors.initials: DA
authors.lastname: Jabs
authors.forename: H J
authors.initials: HJ
authors.lastname: Kaplan
authors.forename: W R
authors.initials: WR
authors.lastname: Freeman
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy*; D018450:Disease Progression; D017245:Foscarnet / Q000627:therapeutic use*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D016879:Salvage Therapy
chemical_list: D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D017245:Foscarnet; D015774:Ganciclovir